Monster Beverage MNST

Consumer Defensive · Beverages - Non-Alcoholic · Synthos Deep Dive · 2026-08-04

$46.86

Hold

—

The Overview

Monster makes energy drinks. Coca-Cola's trucks deliver them. That arrangement means Monster gets a global distribution network without owning any of it, which is why a company with $8.3 billion of sales employs only 6,332 people and spends about $132 million a year on equipment.

The economics are exceptional. Monster keeps about 56 cents of gross profit on every dollar of sales and about 23 cents of net profit. It has no debt at all, and roughly $3.25 billion of cash and investments sitting on the balance sheet. It earns about 25% a year on shareholders' money.

And it just got faster, not slower. In the March quarter, sales rose 26.9% — 22.1% if you strip out currency moves. That is remarkable for a company this size in a category this old, and it is the reason the stock is up 60% over the past year.

So what is the problem? Price. You pay about 45 times last year's profit and about 36 times what analysts expect for 2027. Analysts expect earnings to grow about 13% a year. Paying 36 times for 13% growth means you are paying nearly three years of growth for one year of it. If everything goes right, you get a decent return. If growth slows back toward the 12% it has averaged over five years, you probably do not.

Two housekeeping items you should know about. First, the company reports results in two days, on August 6. Second, it is splitting its stock two-for-one on August 10 — so on August 11, the price on your screen will be about $47 instead of $94, and you will own twice as many shares. That is a cosmetic change and worth nothing, but it will be confusing if you are not expecting it. Neither event is anywhere in the data feed this analysis is built from; both were found by reading the filings.

Our estimate of value is $95 against a $94 price. That is not a call. It is an admission that we cannot find an edge here, and that saying so is more useful than manufacturing one.

Downside Risk 4/10. No debt, large net cash, low beta — but a 45x multiple is its own risk.
Growth Quality 8/10. Accelerating, organic, margin-expanding. The cleanest growth in this batch.
Exponential Potential 4/10. Geographic penetration of an existing product. Real, but ordinary.

Putting a number on it: our fair-value estimate is $95 against a current price of $46.86 — real upside if our numbers are right.

Our summary metrics

Downside Risk (lower = safer)4/10Moderate

"Rated 4 — the lowest financial risk in this batch, offset by the highest valuation risk. The balance sheet is close to pristine: ZERO total debt at 2025-12-31 (against $374.0M a year earlier, since repaid), $2,088.0M of cash, $677.1M of short-term investments and $487.3M of long-term investments — approximately $3,252M of gross investments and cash, or $3.33 per share — against $1,735M of total liabilities on $9,989M of assets. Current ratio 3.26x, financial leverage 1.24x, interest coverage 806x. Return on equity 25.5%, return on invested capital 21.9%, return on assets 18.7%. Beta 0.53, the lowest in this batch. Free cash flow of $1,966M on $2,098M of operating cash flow with capex of only $132.3M — 5.6% of operating cash flow — and management guiding capital expenditure 'likely to be less than $250.0 million through March 31, 2027.' There is no leverage risk, no funding risk and no covenant risk here. What there is: a 45.3x trailing multiple, 36.2x FY2027 consensus, and a 10.24x EV/sales that leaves no room for a growth disappointment. Regulatory risk is real and specifically enumerated by the company itself in its 2026-07-08 forward-looking-statements language — 'the impact of the current U.S. presidential administration's policies on our energy drinks due to concerns about sugar-sweetened beverages, particular ingredients, such as food dyes, and the -generally recognized as safe- (GRAS) process' and 'proposed or adopted domestic and/or foreign legislation to limit or restrict the sale of energy drinks (including the prohibition of the sale of energy drinks to certain demographics... or pursuant to certain governmental programs, such as the Supplemental Nutrition Assistance Program (SNAP)).' Distribution concentration is the other structural exposure: the company names 'our extensive commercial arrangements with The Coca-Cola Company (TCCC) and, as a result, our future performance's substantial dependence on the success of our relationship with TCCC.' The Alcohol Brands segment fell 21.8% to $134.7M in FY2025 and remains unprofitable by the company's own framing."

Growth Quality8/10Very High

"Rated 8 — the cleanest growth record in this batch, and it is accelerating rather than decaying. Net sales: $4,599M (2020), $5,541M (2021), $6,311M (2022), $7,140M (2023), $7,493M (2024), $8,294M (2025) — a 12.5% compound rate over five years with no down year. The March 2026 quarter was $2,353.3M against $1,854.6M, +26.9% reported and +22.1% on a foreign-currency-adjusted basis, with the Monster Energy Drinks segment alone +27.6% reported and +22.8% currency-adjusted. Margins are widening at the same time: gross margin 55.8% in FY2025 against 54.0% in FY2024 'primarily the result of the Pricing Actions and supply chain optimization'; Q1 2026 operating margin 31.0% against 30.7%; operating income $730.0M, +28.1%. Earnings per diluted share: $1.12 (2022), $1.54 (2023), $1.49 (2024), $1.94 (2025). Consensus wants $9,577M of revenue in FY2026 (+15.5%), $10,439M in FY2027 (+9.0%) and $11,386M in FY2028 (+9.1%), with EPS of $2.302, $2.604 and $2.931 — 18.7%, then 13.1%, then 12.6%. Note the shape of that: consensus models the current 22% currency-adjusted growth decaying to 9% within two years. What holds this at 8 rather than 9: the Q1 comparison is against a genuinely weak March 2025 quarter ($1,854.6M, itself DOWN from $1,899M in Q1 2024), so the two-year stack is 23.9%, or 11.3% annualised — good, but not 27%. Also, one of three segments is shrinking: Alcohol Brands −21.8% to $134.7M."

Exponential Potential4/10Moderate

"Rated 4 — a category-expansion story, not a technology one. Monster's growth mechanism is geographic and demographic penetration of a product that already exists, distributed through a partner's network. The evidence that it still works: EMEA revenue $1,899.6M in FY2025 against $1,228.7M in FY2022 (+54.6% in three years), Asia Pacific $624.1M against $456.2M (+36.8%), Latin America $698.0M against $510.6M (+36.7%) — against U.S. and Canada at $5,072.7M, still 61.2% of the total. International is the compounding engine and it is roughly 39% of sales, so there is genuine runway. The optionality inside the file is thin. Alcohol Brands, the one genuine adjacency, is going backwards: $184.9M (2023), $172.3M (2024), $134.7M (2025), and the company's own risk language references 'achieving profitability within our Alcohol Brands segment' as an open question. The brand portfolio is extraordinary in breadth — the 2026-07-08 release lists more than two dozen marks — but breadth of SKUs inside one category is not optionality. The scaling law here is the same one Coca-Cola has run for a century: put the product in more places. A 4: a durable, high-return, genuinely global franchise with an ordinary growth mechanism and one failed adjacency."

Fair value$95 $70–$118

What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)

Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.

Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.

WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.

HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.

AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

The Road Ahead

What we expect to matter in each window, and the evidence that would prove us wrong.

Short term 0-6 months

Neutral

Driver: "An earnings print in two days and a stock split in six, into a stock that has already run 59.6% in twelve months. Monster closed 2026-08-04 at $94.18, up 0.67%, which is 0.4% above a 50-day moving average of $93.77 and 16.5% above a 200-day average of $80.85 — a strongly trending configuration. It is 5.8% below the 52-week high of $99.94 and 59.5% above the low of $59.04, and the maximum drawdown from peak over the measured window is also 5.8%, i.e. the stock has not had a meaningful setback in a year. Against that, RSI is 41.99 — the softest reading in this batch relative to trend position — and MACD is only +0.35, so short-term momentum has stalled even as the trend remains intact. Three-month return +25.2% against SPY's +7.6%; twelve-month +59.6% against SPY's +24.3%. The August 6 print is the event: consensus wants $0.581 of EPS and $2,428.9M of revenue, which would be +15.0% year on year against the +26.9% just delivered — so the bar embeds a sharp deceleration, and either direction of surprise moves a 36x-forward stock hard. We are not taking a position two days ahead of it."
What we’re watching: "The 2026-08-06 print, and specifically three numbers rather than the headline: currency-adjusted net sales growth (22.1% in Q1; the consensus revenue estimate of $2,428.9M implies roughly 15% reported, so the gap between reported and currency-adjusted growth is where the surprise lives); gross margin, which was 55.8% for FY2025 against 54.0% for FY2024 on 'Pricing Actions and supply chain optimization' and is the swing factor in earnings; and the Alcohol Brands line, down 21.8% in FY2025 to $134.7M, where any impairment would be a first. Also watch the buyback pace against the ~$900M of combined authorisation (the new $500.0M approved 2026-05-14 plus approximately $400.0M remaining), which ran at only $103.6M for all of FY2025 against $3,772M in FY2024. And note the mechanical calendar: record date for the 2-for-1 split was 2026-07-24, distribution after the close 2026-08-10, split-adjusted trading from 2026-08-11."
Confidence: Medium

Medium term 6-24 months

Tailwind

Driver: "The medium-term case is straightforward and is about international penetration plus margin. EMEA grew from $1,228.7M in FY2022 to $1,899.6M in FY2025, Asia Pacific from $456.2M to $624.1M, and Latin America from $510.6M to $698.0M — while U.S. and Canada, at $5,072.7M, remains 61.2% of the total, so the faster-growing 39% is compounding against a large, slow base. Gross margin has moved 180 basis points in a year on pricing and supply-chain work with the company describing both as ongoing. Capital intensity is negligible: $132.3M of capex against $2,098M of operating cash flow, and guidance of 'less than $250.0 million through March 31, 2027,' which means essentially all earnings are distributable. Consensus wants 15.5% revenue growth in FY2026 decelerating to 9.0% in FY2027 and 9.1% in FY2028, with EPS reaching $2.93 by FY2028. If the current 22% currency-adjusted rate holds even half-way toward that decay, the FY2027 and FY2028 numbers are too low. That is the bull case and it is the only route to a return from here, because the multiple is doing no work."
What we’re watching: "Whether the growth reacceleration is durable or a comp effect. The March 2026 quarter's +26.9% is measured against a March 2025 quarter of $1,854.6M that was itself DOWN from $1,899.5M a year earlier — the two-year stack is +23.9%, or 11.3% annualised, against a five-year compound rate of 12.5%. Two more quarters at 20%+ currency-adjusted would settle it. Watch also: gross margin against the 55.8% FY2025 base; whether the Coca-Cola distribution relationship, which the company names as a dependency, changes in any respect; whether Alcohol Brands is fixed, sold or written down; the regulatory file the company itself flags — SNAP eligibility, GRAS process, food dyes, age restrictions and container-size rules; and whether the ~$900M of repurchase authorisation is actually deployed, given that FY2025 saw only $103.6M against $3,772M in FY2024."
Confidence: Medium

Long term 2+ years

Tailwind

Driver: "Long-run Monster is one of the small number of consumer franchises with a genuine, durable, high-return position, and the question has never been whether it is a good business but what it is worth. Twenty-five per cent returns on equity, 22% on invested capital, 56% gross margins, zero debt, negligible capital intensity, and a distribution partnership with the largest beverage network on earth are a combination that survives most things. The category itself continues to take share from carbonated soft drinks and coffee across every region the company reports. What limits the long-run stance to a tailwind rather than something stronger is that the mechanism is fully understood and fully priced: at 36.2x FY2027 consensus the market is already paying for a decade of the same, and the incremental return has to come from the growth exceeding a consensus that already models 9% revenue and 13% earnings growth. The two things that could genuinely change the trajectory — a successful alcohol franchise, or a regulatory regime that restricts the category — are one failing and one out of the company's hands."
What we’re watching: "The regulatory file, which is the only identified threat to the franchise rather than to the multiple: the GRAS process, food-dye rules, sugar-sweetened-beverage policy, SNAP eligibility, age and container-size restrictions, and excise taxes — all enumerated by the company in its own forward-looking-statement language. The Coca-Cola relationship, described by Monster as a substantial dependency; note the knowledge base's single claim on this company is about Coca-Cola's ~20% stake and 'missing full ownership was a valuation call, not a strategic failure,' which is a live question about whether that stake ever becomes a bid. International mix, currently ~39% and rising. Whether Alcohol Brands survives. And the founder-executive transition: Rodney C. Sacks and Hilton H. Schlosberg have run this company for three decades and both executed large non-open-market share transfers on 2026-05-22 — Schlosberg 1,151,867 shares and Sacks 697,495, both coded J-Other at $0."
Confidence: Medium

Exponential Potential

Exponential Potential4/10Moderate

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 22%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $47, earnings would have to compound roughly 22% a year for 10 years (9% discount rate). Analysts forecast ~2%/yr, so the market is pricing in MORE than what the Street expects.

> ## ⚠ EARNINGS IN TWO DAYS — AND A STOCK SPLIT IN SIX

> Monster reports second-quarter 2026 results on 2026-08-06, two days after this dive is struck. Vendor consensus is $0.581 of EPS and $2,428.9M of revenue — the latter implying +15.0% year-on-year growth against the +26.9% just delivered in the March quarter, so the bar embeds a sharp deceleration.

> Separately, and absent from every vendor field: on 2026-07-08 the Board declared a 2-for-1 stock split, effected as a 100% stock dividend. Record date 2026-07-24. Distribution after the close on 2026-08-10. Split-adjusted trading begins 2026-08-11 — six days after this dive. Every price, per-share, estimate, moving-average and 52-week figure in this document is PRE-SPLIT and will halve mechanically. This changes nothing about value and everything about how the numbers on this page will look next week.

> The verdict below is set with both events as inputs. It is a Hold, and the timing is part of why.

Reference table

Street consensus	$96.27 (+2.2%) · median $95 · high $105 (+11.5%) · low $86 (−8.7%) · 1 strong buy / 22 buy / 18 hold / 3 sell across 44 analysts, vendor consensus label Buy. Note the disconnect: 23 of 44 rate it Buy while the consensus target implies 2.2% of upside
Valuation	45.3x trailing · 40.9x FY2026E ($2.302) · 36.2x FY2027E ($2.604) · 32.1x FY2028E ($2.931) · EV/sales 10.24x · EV/EBITDA 32.5x · P/B 10.56x · forward PEG 3.46x
Growth	Q1 2026 net sales $2,353.3M, +26.9% reported and +22.1% currency-adjusted; Monster Energy Drinks segment +27.6% / +22.8%; operating income $730.0M, +28.1%; operating margin 31.0% vs 30.7%
Balance sheet	ZERO total debt · cash $2,088.0M + short-term investments $677.1M + long-term investments $487.3M = approximately $3,252M, or $3.33 per share · current ratio 3.26x · interest coverage 806x · ROE 25.5% · ROIC 21.9%
Cash generation — VERIFIED CLEAN	FY2025 operating cash flow $2,098M less capex $132.3M = free cash flow $1,966M, arithmetic correct and capex corroborated by guidance of "less than $250.0 million through March 31, 2027." Free-cash-flow yield 2.25% — as reported, no correction required
Corporate actions ABSENT from the payload	(1) 2-for-1 stock split declared 2026-07-08, split-adjusted trading from 2026-08-11. (2) A new $500.0M repurchase authorisation approved 2026-05-14, on top of ~$400.0M remaining — approximately $900M available against $103.6M actually repurchased in all of FY2025. (3) Director Mark J. Hall's resignation effective 2026-08-01, reducing the Board from ten to nine
Technicals	+0.4% above the 50-DMA ($93.77), +16.5% above the 200-DMA ($80.85); −5.8% from the 52-week high of $99.94, +59.5% above the low of $59.04; RSI 41.99; MACD +0.35; 12-month +59.6% vs SPY +24.3%
Knowledge base	54 raw hits, 1 name-level claim, and it is about Coca-Cola. The sweep is discarded in its entirety — "Celsius" resolves to Celsius Network the crypto lender, not the energy-drink competitor

What the experts actually said

No independent expert claims in the Synthos knowledge base yet for MNST — this dive is fundamentals- and technicals-driven, not panel-driven.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Bollinger Bands 20-day average ± 2 standard deviations

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

RSI (14) momentum gauge · 0–100

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 47.

MACD 12 / 26 / 9 · trend & momentum

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Relative performance vs S&P 500 & its sector (XLP (sector)), set to 100 a year ago

Solid = MNST · dashed = S&P 500 · dotted = XLP (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$46.86

Market cap$92B

P/E trailing43×

P/E FY26E / FY27E40× / 36×

EV / Sales9.6×*

EV / EBITDA29.8×*

Gross margin55.5%

Net margin23.1%

Dividend yield0.00%

Beta0.524

52-wk range$31 – $50

RSI(14)57

50 / 200-DMA$48 / $42

12-mo return+52% (SPY +19%)

Street target$98 ($90–$105)

Analyst grades22 Buy · 18 Hold · 3 Sell

FMP ratingB

Next earnings2026-08-06 (Q2 2026 earnings, TWO DAYS AWAY; vendor consensus EPS $0.581 and revenue $2,428.9M, implying +15.0% revenue growth on the year-ago $2,111.6M and +3.2% sequentially on Q1's $2,353.3M). Separately, the 2-for-1 stock split declared 2026-07-08 has a record date of 2026-07-24, is distributed after the close on 2026-08-10, and begins split-adjusted trading 2026-08-11 — six days after this dive.

* Enterprise value recomputed in-house: the data vendor nets cash but omits short-term investments, overstating EV for cash-rich balance sheets. EV multiples marked * use market cap + total debt − cash − short-term investments.

1. What the business is

Monster Beverage is a holding company whose subsidiaries develop and market energy drinks, sold through third-party bottlers and distributors — predominantly The Coca-Cola Company's network. 6,332 employees, chief executive Hilton H. Schlosberg (Vice Chairman and CEO), listed on NASDAQ since 1985, beta 0.53.

Three reportable segments, FY2025 (seg_prod, verified to tie):

Segment	FY2025	share	FY2024	YoY
Monster Energy Drinks	$7,665.9M	92.7%	$6,864.6M	+11.7%
Strategic Brands	$468.7M	5.7%	$432.2M	+8.4%
Alcohol Brands	$134.7M	1.6%	$172.3M	−21.8%
Sum	$8,269.3M		$7,469.1M
`inc_a` revenue	$8,294M		$7,493M
Tie	99.7%		99.7%

The segment block ties to within 0.3% in both years and is accepted. The 0.3% residual is the "Other" category the vendor drops after FY2023. This is a clean result and is recorded as one — seg_prod failed the sum test on MDT (147%), NEM, JCI (56.4%), CDNS (178.6%), CSX (159.7%) and, in this same batch, UPS (72.8%).

Geography, FY2025 (seg_geo, verified to tie exactly):

Region	FY2025	share	FY2022	3-yr growth
U.S. and Canada	$5,072.7M	61.2%	$4,115.5M	+23.3%
EMEA	$1,899.6M	22.9%	$1,228.7M	+54.6%
Latin America & Caribbean	$698.0M	8.4%	$510.6M	+36.7%
Asia Pacific	$624.1M	7.5%	$456.2M	+36.8%
Sum	$8,294.3M	100.0%

$8,294.3M against inc_a revenue of $8,294M — an exact tie. The geography block is clean, correctly labelled, and reports four genuine regions with no aggregate double-counting. Recorded as a second clean result on a defect class that has failed repeatedly elsewhere.

The shape of the business it reveals: 61% of sales are still North American, and the fastest-growing region is EMEA at +54.6% over three years. International is roughly 39% of the total and rising, which is the medium-term growth mechanism.

2. The March 2026 quarter — the acceleration, and its comp

From the 10-Q filed 2026-05-08, verbatim:

> "Net sales were $2.35 billion for the three-months ended March 31, 2026, an increase of approximately $498.7 million, or 26.9% higher than net sales of $1.85 billion for the three-months ended March 31, 2025... Net changes in foreign currency exchange rates had a favorable impact on net sales of approximately $89.3 million... Net sales on a foreign currency adjusted basis increased 22.1%."

> "Net sales for the Monster Energy® Drinks segment were $2.19 billion... an increase of approximately $473.1 million, or 27.6%... Net sales for the Monster Energy® Drinks segment on a foreign currency adjusted basis increased 22.8%."

> "Operating income was $730.0 million... an increase of approximately $160.2 million, or 28.1%... Operating income as a percentage of net sales increased to 31.0% for the three-months ended March 31, 2026 from 30.7%."

And on the margin, from the 10-K: "Gross profit as a percentage of net sales increased to 55.8% for the year ended December 31, 2025 from 54.0% for the year ended December 31, 2024. The increase... was primarily the result of the Pricing Actions and supply chain optimization, partially offset by higher promotional allowances and geographical sales mix."

The full quarterly series (vendor inc_q, cross-checked against earn_cal):

Quarter	Revenue	YoY	Operating income	Op. margin	GAAP diluted EPS	Reported EPS (`earn_cal`)	vs est
Q1 2024	$1,899.5M	—	$542.0M	28.53%	$0.42	—	—
Q2 2024	$1,901.4M	—	$527.2M	27.73%	$0.41	—	—
Q3 2024	$1,881.4M	—	$479.9M	25.51%	$0.38	—	—
Q4 2024	$1,812.3M	—	$381.2M	21.03%	$0.28	—	—
Q1 2025	$1,854.6M	−2.4%	$569.7M	30.72%	$0.45	$0.47	vs $0.459
Q2 2025	$2,111.6M	+11.1%	$631.6M	29.91%	$0.50	$0.52	vs $0.481
Q3 2025	$2,197.1M	+16.8%	$675.4M	30.74%	$0.53	$0.56	vs $0.479
Q4 2025	$2,131.1M	+17.6%	$542.6M	25.46%	$0.46	$0.51	vs $0.484
Q1 2026	$2,353.3M	+26.9%	$730.0M	31.02%	$0.58	$0.58	vs $0.527

Four observations.

First, the inflection is genuine and it is five quarters old, not one. The year-on-year line runs −2.4%, +11.1%, +16.8%, +17.6%, +26.9%. That is a monotonic acceleration across five consecutive quarters, which is a much stronger pattern than a single surprising print.

Second, the comparison base flatters the headline and we say so. Q1 2025's $1,854.6M was itself down 2.4% from Q1 2024's $1,899.5M. The two-year stack from Q1 2024 to Q1 2026 is +23.9%, or 11.3% annualised — essentially the company's five-year compound rate of 12.5%, not 27%. The currency-adjusted +22.1% is the honest figure for the year, and it is still excellent; the reported +26.9% is not the run rate.

Third, the margin is doing real work. Operating margin of 31.02% in Q1 2026 is the highest in the nine-quarter series, and gross margin rose 180 basis points across FY2025 on pricing and supply-chain measures the company describes as ongoing. Q4 is seasonally the weakest quarter (25.5% in each of the last two years), so the September quarter is the better comparison for whether the margin gain persists.

Fourth, the beat pattern is consistent and modest: +2.4%, +8.2%, +17.0%, +5.4%, +10.1%. Five consecutive beats, none of them enormous. Consensus is running slightly behind and adjusting each quarter, which is the pattern of a genuine, under-modelled acceleration rather than a one-off.

A basis note that matters for reading the table. earn_cal epsActual exceeds inc_q GAAP diluted EPS in four of the five quarters — $0.47 vs $0.45, $0.52 vs $0.50, $0.56 vs $0.53, $0.51 vs $0.46 — and matches exactly in the fifth ($0.58 vs $0.58). The reported figures are on an adjusted basis and the gaps are small (2 to 5 cents, i.e. 4-11%). This is a far smaller adjustment burden than most names in this programme and it is stated so the beat percentages above are read correctly: they are beats on adjusted EPS, and the adjustment ran to zero in the most recent quarter.

3. Cash generation and the balance sheet — the clean end of the file

The capex/free-cash-flow check was run first, per standing instruction, and Monster passes.

Year	OCF	Capex	FCF	D&A	capex/D&A	capex/revenue
FY2022	$887.7M	−$212.2M	$675.5M	$61.2M	3.47x	3.4%
FY2023	$1,718M	−$234.7M	$1,483M	$68.9M	3.41x	3.3%
FY2024	$1,929M	−$264.1M	$1,664M	$80.4M	3.28x	3.5%
FY2025	$2,098M	−$132.3M	$1,966M	$114.4M	1.16x	1.6%

Free cash flow is computed by subtracting capex, and the arithmetic is correct in every year. capexToDepreciationTTM of 1.049 is above 1.0 — no zero-capex, negative-capex or added-back-capex signature. The FY2025 halving of capex is corroborated by the 10-Q's forward guidance: "we estimate that capital expenditures (exclusive of common stock repurchases) are likely to be less than $250.0 million through March 31, 2027." The 2.25% free-cash-flow yield stands as reported. No correction is applied.

That yield is the whole valuation argument in one number. Monster converts earnings to cash almost perfectly — freeCashFlowOperatingCashFlowRatioTTM is 0.944 and incomeQualityTTM is 1.081 — and a 2.25% yield on near-perfect conversion is simply what a 45x multiple looks like.

The balance sheet:

	2025-12-31	2024-12-31	2023-12-31
Cash and equivalents	$2,088.0M	$1,533M	$2,298M
Short-term investments	$677.1M	$0M	$955.6M
Long-term investments	$487.3M	$0.006M	$76.4M
Inventory	$799.6M	$737.1M	$971.4M
Total assets	$9,989M	$7,719M	$9,687M
Goodwill	$1,332M	$1,332M	$1,418M
Intangibles	$1,379M	$1,414M	$1,427M
Total debt	$0M	$374.0M	$0M
Total liabilities	$1,735M	$1,761M	$1,458M
Total stockholders' equity	$8,254M	$5,958M	$8,229M
Retained earnings	$9,354M	$7,449M	$5,940M

Zero debt at year-end 2025, the $374.0M drawn in 2024 having been repaid — the 10-Q confirms Q1 2025 financing outflows were "primarily due to repayments on the Credit Facilities." Total cash and investments of approximately $3,252M is $3.33 per share, 3.5% of the market capitalisation.

The equity swing from $8,229M (2023) to $5,958M (2024) to $8,254M (2025) is the buyback: cf_a records −$3,772M of repurchase in FY2024 against −$103.6M in FY2025. FY2024's was the large accelerated programme; FY2025's repurchase was 2.7% of the prior year's, which is why the equity rebuilt. Against that, the Board approved a new $500.0 million authorisation on 2026-05-14 with approximately $400.0 million remaining on the August 2024 plan — approximately $900 million of capacity against $103.6M of actual FY2025 spending. Whether that capacity is used is a live and watchable question, not a fact.

4. The two corporate actions the payload never heard of

Both were found by reading the 8-Ks. Neither appears in any vendor field.

The 2-for-1 stock split — 2026-07-08, effective in six days

From Exhibit 99.1 to the 8-K filed 2026-07-08, verbatim:

> "MONSTER BEVERAGE DECLARES TWO-FOR-ONE STOCK SPLIT... Monster Beverage Corporation (NASDAQ: MNST) today announced that its Board of Directors has approved and declared a 2-for-1 split of its common stock that will be effected in the form of a 100% stock dividend. Each stockholder of record on July 24, 2026 will receive a dividend of one additional share of common stock for each then-held share, to be distributed after close of trading on August 10, 2026. The Company anticipates its common stock to begin trading at the split-adjusted price on August 11, 2026."

Consequences that must be stated:

Every price, per-share, moving-average, 52-week and estimate figure in this dive is PRE-SPLIT. On 2026-08-11 the quoted price becomes approximately $47.09, the FY2027 consensus EPS becomes approximately $1.302, the 50-day average becomes approximately $46.88, and the share count doubles to approximately 1.956 billion. The multiples, the market capitalisation and the fair values are unchanged.
The vendor payload contains no trace of it. quote, est, tech, inc_q and km_ttm are all pre-split, which is correct as of 2026-08-04 and will be wrong from 2026-08-11 unless re-pulled. Any comparison of this file against a post-2026-08-11 pull will show a 50% "decline" that is entirely mechanical. The standing SYN_FORCE=1 discipline applies with unusual force here.
A stock split creates no value and this dive assigns it none. It is reported because it is a scheduled, dated, material change to how the security trades within the horizon of the dive.

A new $500.0 million repurchase authorisation — 2026-05-14

From Item 8.01 of the 8-K filed 2026-05-15:

> "On May 14, 2026, the Board of Directors of the Company authorized a new repurchase program for the repurchase of up to an additional $500.0 million of the Company's outstanding shares of common stock. As of May 14, 2026, approximately $400.0 million remained available for repurchase under the Company's previously authorized repurchase program."

Approximately $900 million of combined capacity, roughly 1.0% of the market capitalisation. Against FY2025's actual repurchase of $103.6M, this is capacity rather than commitment. Nothing in the vendor payload records the authorisation.

A Board departure — 2026-06-04

Item 5.02 of the 8-K filed 2026-06-04: Mark J. Hall, a director, gave notice of his intention to resign from the Board effective 2026-08-01 and as an employee of Monster Energy US LLC effective 2027-04-01, "not as a result of any disagreement." The Board is reduced from ten to nine directors. Recorded for completeness; not material to the valuation.

5. Valuation — priced in or room?

At $94.18 (market cap $92.11B, 977.9M shares outstanding per the 10-Q):

	Trailing	FY2026E	FY2027E	FY2028E	FY2029E
Consensus EPS	$2.077	$2.302 (10)	$2.604 (10)	$2.931 (8)	$3.278 (6)
EPS growth	—	+18.7% (vs $1.94 FY2025)	+13.1%	+12.6%	+11.8%
P/E	45.3x	40.9x	36.2x	32.1x	28.7x
Consensus revenue	$8,788M (TTM)	$9,577M (18)	$10,439M (18)	$11,386M (16)	$12,452M (15)
Revenue growth	—	+15.5%	+9.0%	+9.1%	+9.4%
EV/sales	10.24x	—	—	—	—
EV/EBITDA	32.5x	—	—	—	—
Forward PEG	3.46x	—	—	—	—

Estimate coverage is thin on EPS and thick on revenue, which is unusual and worth noting. 18 analysts on FY2026 and FY2027 revenue but only 10 on EPS in each; 8 on FY2028 EPS and 6 on FY2029 and FY2030. The FY2027 EPS range is $2.464 to $2.833, a 15.0% spread. The FY2029 and FY2030 rows are used only as directional cross-checks.

est.ebitdaAvg and est.ebitAvg are REJECTED — fixed-ratio fabrication, every forward year. ebitdaAvg is exactly 29.73% of revenueAvg in FY2026, FY2027, FY2028, FY2029 and FY2030; ebitAvg is exactly 28.66% in every one. Tested against reality: FY2025 actual EBITDA per inc_a was $2,604M on $8,294M — a 31.40% margin — against the estimate block's implied 29.72%, so the fabricated ratio is 5.4% below the actual margin. The block is a formula. All forward valuation uses epsAvg. Fourteenth consecutive name.

Peer set is a consumer-staples market-cap cohort, not a competitor set. ABEV, CCEP, CL, COKE, DEO, KDP, KOF, KR, MDLZ, TGT. Monster's actual competitors — Celsius Holdings, Red Bull (private), Bang (acquired by Monster) — are absent. Kroger and Target are retailers, Colgate is oral care, Diageo is spirits. No peer multiple comparison is drawn.

5a. What today's price assumes (the inversion)

At $94.18 — 40.9x FY2026 consensus, 36.2x FY2027, 10.24x EV/sales — the price embeds:

Revenue of $9,577M in 2026 and $10,439M in 2027. (Consensus; 18 analysts each.) Q1 delivered $2,353.3M. The FY2026 figure requires $7,224M across the remaining three quarters, an average of $2,408M, against the $2,428.9M consensus for the June quarter — so consensus is modelling essentially flat sequential revenue for the rest of the year. On a year-on-year basis that is +15.5% for the full year against +26.9% in Q1, i.e. deceleration to roughly +11% in the back half.
EPS reaches $2.60 by FY2027, i.e. 13.1% growth off a 18.7% year. (Consensus; 10 analysts.) This is the most fragile assumption in the price, and it is fragile in an unusual direction: it may be too LOW. If the currency-adjusted 22.1% rate persists even at 16-18%, FY2027 EPS lands nearer $2.85-2.95 and the stock is 32x rather than 36x. The bear risk is the mirror image — a return to the 12.5% five-year compound rate puts FY2027 nearer $2.45.
Gross margin holds above 55%. (Company disclosure, half-weighted; the 10-K states 55.8% for FY2025 against 54.0% for FY2024.) The 180-basis-point gain is attributed to "Pricing Actions and supply chain optimization"; pricing gains do not repeat annually and the aluminium and Midwest Premium exposure the company names in its risk language runs the other way.
The market keeps paying 32-41x forward earnings. (Our number.) At 30x FY2027E the stock is $78; at 42x it is $109. Monster has traded in a 28-45x forward band for most of the last decade, so 36.2x is mid-to-upper range and there is no structural reason for it to move in either direction.
The regulatory environment does not change. (Company disclosure, half-weighted.) The company's own 2026-07-08 risk language names the GRAS process, food-dye policy, sugar-sweetened-beverage policy, SNAP eligibility, demographic sale prohibitions and container-size restrictions. None of these is in any estimate in this file.

5b. The return bridge (why the multiple moves)

Expected return over the next twelve months decomposes as: EPS growth (+13.1% from FY2026E $2.302 to FY2027E $2.604) + multiple drift (roughly HELD; our base of $95 is 36.5x FY2027E against 36.2x today, +0.8%) + shareholder yield (approximately +1.0%, being the ~$900M of authorisation if fully used against a $92.1B market capitalisation; no dividend) ≈ +14% to +15% on the consensus path.

Our base holds the multiple, and here that is a genuinely contestable choice rather than a conservative default. The case for expansion: growth has accelerated for five consecutive quarters, margin is widening, the balance sheet is debt-free, and the market has historically paid up to 45x for this franchise. The case for compression: 36.2x for 13% growth is a PEG near 2.8, the company is $8.3 billion of revenue rather than $2 billion, and the international mix that drives the growth is the part most exposed to currency.

We hold it, and the consequence is that our fair value lands within 1% of spot. That is not a hedge — it is the arithmetic. On these estimates and this multiple, the stock is worth what it costs.

Note what that makes the return: essentially all of it is earnings growth. There is no dividend, the buyback is roughly 1% of market cap if fully executed, and we assume no re-rating. A 13-15% expected return that depends entirely on consensus earnings being met is a reasonable thing to own and an unreasonable thing to buy two days before a print at 36x.

5c. Variant perception (where we differ, what would surprise)

On the level we have essentially NO variant perception and we state it. Our $95 is 1.3% below the street's $96.27 and 0.9% above spot. The interesting observation is not our disagreement with the street but the street's disagreement with itself: 23 of 44 analysts rate Monster a Buy, yet the consensus target implies 2.2% of upside and the median target of $95 implies 0.9%. That is a ratings distribution that has not been reconciled to the price targets behind it, and it is a reason to treat the "Buy" consensus label as uninformative here.
Where we do differ is on the direction of estimate risk, and we think it is asymmetric to the upside. Consensus models revenue growth decaying from +26.9% (actual Q1) to +15.5% (FY2026) to +9.0% (FY2027). Currency-adjusted growth was +22.1% in Q1 and the acceleration has run for five consecutive quarters — −2.4%, +11.1%, +16.8%, +17.6%, +26.9%. Watchable number: currency-adjusted net sales growth in the 2026-08-06 print. Above 18% and the FY2027 consensus of $10,439M is too low; below 12% and the deceleration thesis is confirmed and the multiple has no support.
We think the knowledge base's silence on this name is itself a finding, and it is caused by a data defect rather than by an absence of interest in the sector. "Celsius" — Monster's most-discussed listed competitor — resolves in this store exclusively to Celsius Network, the crypto lender that failed in 2022, confirmed by forward_guidance (2025-06-25) naming it alongside BlockFi, Genesis, Voyager, 3AC and Alameda. Any competitive intelligence the store might carry on the energy-drink category is therefore either absent or unreachable through the obvious term. This is a homograph collision of the CEG/PWR/USB class and it is reported as one.
Positive surprise that would force a re-rate: currency-adjusted growth above 20% in the August print with gross margin above 56%, which would make the FY2027 consensus of $2.60 visibly too low; or the ~$900M of repurchase authorisation actually deployed, which after a year of $103.6M would signal that management shares our reading of the growth.
Negative surprise that would break the thesis: currency-adjusted growth below 12%, i.e. a return to trend, which at 36x is worth roughly 20% of the price; a gross-margin retreat toward 54% on aluminium or Midwest Premium costs; a US regulatory action on SNAP eligibility, the GRAS process or age-restricted sale; any change to the Coca-Cola distribution arrangement, which the company itself names as a substantial dependency; or an Alcohol Brands impairment after a 21.8% revenue decline.

Synthos fair values

All three anchors are multiples of the FY2027 consensus EPS distribution (mean $2.604, low $2.464, high $2.833, 10 analysts). All figures are PRE-SPLIT; halve every one from 2026-08-11.

Bear ~$70 — 28.4x the FY2027 consensus LOW of $2.464. Cross-check: 30.4x FY2026E; 18.6% above the 52-week low of $59.04; approximately 7.5x book value. The scenario: the acceleration proves to be a comp effect, currency-adjusted growth returns to the 12.5% five-year trend, gross margin gives back the 2025 pricing gain, and the multiple compresses toward the bottom of its decade band. −25.7%.
Base ~$95 — 36.5x the FY2027 consensus MEAN of $2.604. Cross-check: 41.3x FY2026E; 32.4x FY2028E; 5.0% below the 52-week high. The scenario: growth decelerates roughly as consensus models, margin holds near 56%, the balance sheet stays debt-free, and the multiple does not move. +0.9%.
Bull ~$118 — 41.6x the FY2027 consensus HIGH of $2.833. Cross-check: 40.3x FY2028E; 18.1% above the 52-week high of $99.94. The scenario: currency-adjusted growth holds near 20%, international mix continues to expand toward 45% of sales, gross margin passes 57%, the full ~$900M authorisation is deployed, and the market pays the top of the historical band for a debt-free 25%-ROE compounder that has just reaccelerated. +25.3%.

Base is 0.9% above spot; asymmetry 0.98:1 (25.7% down, 25.3% up), with no dividend and a buyback worth roughly 1% if fully used. A payoff ratio below 1:1 and a base case inside 1% of spot is a Hold in any framework, and the two-day earnings proximity makes it a Hold with conviction rather than a Hold by default.

6. Knowledge base — a sweep discarded in its entirety

Raw hits: 54. After a case-sensitive entity re-run: 1. Used: 1. Discarded: 53.

The sweep ran entity terms MNST, Monster, Monster Beverage, Celsius and CELH, plus free text on monster, energy drink, caffeine and Celsius, across the full distilled claim store. It returned 54 hits across 25 channels. One names the company.

The single surviving claim, verbatim:

> 2024-02-18 · bullish · conviction 55 · horizon: thesis · entities: Coca-Cola, KO, Monster · channel: business_breakdowns · no named speaker · skill 1.0

> "Coke's ~20% Monster stake plus distribution access shows the network's pull; missing full ownership was a valuation call, not a strategic failure."

Note what that claim is about. It is a claim about Coca-Cola, in which Monster appears as evidence. It carries no view on Monster's growth, margin, valuation or competitive position. It is used only as the single piece of outside corroboration for the Coca-Cola dependency the company itself names as a principal risk, and it is corroboration of the relationship's importance, not of its durability.

The discards are the instructive part, and they divide into two clean failure modes.

First — a homograph collapse on the competitor, not on the company. Every "Celsius" hit in this store is Celsius Network, the crypto lender that failed in 2022 — not Celsius Holdings, the energy-drink competitor. The dispositive claim is forward_guidance, 2025-06-25, conviction 90: "2022 blowups stemmed from retail deposit aggregation, VC capital flood, high risk appetite, and no prior credit events disciplining behavior" — entities Celsius, BlockFi, Genesis, Voyager, 3AC, Alameda. That is unambiguous. The practical consequence is important and is stated plainly: a sweep that admitted Celsius hits would have imported crypto-credit-crisis claims into a beverage dive at conviction 90, and would have read as substantive. This is the CEG/Constellation-Software pattern in a different sector. Monster's largest listed competitor is effectively invisible to this knowledge base.

Second — free-text noise on two common English words. "Monster" as an adjective supplies hits such as invest_like_the_best (2025-08-19): "Post-WWII employer coverage plus Hill-Burton capacity removed consumer price sensitivity, creating a structural healthcare-cost inflationary monster." "Caffeine" supplies seventeen health-science hits from rhonda_patrick (12), huberman_lab (4) and peter_attia (1) about caffeine metabolism, sleep and adenosine — none of which names a company or bears on an investment. A further claim from business_breakdowns (2024-10-14) uses caffeine as an analogy for nicotine demand.

Conclusion. Breadth 1, claim count 1, net conviction NONE. The knowledge base has no view on Monster Beverage and this dive does not manufacture one. The lane is reported as empty rather than padded, consistent with the treatment of CSX and JCI, and the sweep is discarded in its entirety as noise. Conviction contributes zero to this verdict in either direction, which — given that the verdict is Hold on valuation arithmetic — is at least internally consistent.

7. Data integrity — what we rejected and why

Seven findings. Monster's file is one of the cleanest in this programme on the fundamentals and one of the most incomplete on corporate actions.

1. Capex and free cash flow — CHECKED AND CLEAN. FY2025 operating cash flow $2,098M less capex $132.3M equals free cash flow $1,966M; the subtraction is correct in all four years. capexToDepreciationTTM 1.049, above 1.0, with no zero-capex or negative-capex signature. Corroborated by the 10-Q's guidance of "less than $250.0 million through March 31, 2027." The 2.25% free-cash-flow yield stands as reported; no correction applied.

2. seg_prod ties to 99.7% and seg_geo ties EXACTLY — both ACCEPTED. seg_prod FY2025 sums to $8,269.3M against $8,294M of revenue (99.7%, the residual being the "Other" line the vendor drops after FY2023); seg_geo FY2025 sums to $8,294.3M against $8,294M — an exact tie, with four correctly labelled regions and no aggregate/component double-counting. Both blocks are used. This is a clean result on a defect class that failed on MDT, NEM, JCI, CDNS, CSX and, in this same batch, UPS.

3. TWO CORPORATE ACTIONS AND A BOARD CHANGE ARE ABSENT FROM EVERY VENDOR FIELD. (a) The 2-for-1 stock split declared 2026-07-08, record date 2026-07-24, distributed after the close 2026-08-10, split-adjusted trading from 2026-08-11 — six days after this dive. Every price, per-share, estimate, moving-average and 52-week figure in the payload is pre-split. (b) A new $500.0 million repurchase authorisation approved 2026-05-14, on top of approximately $400.0 million remaining — roughly $900 million of capacity, against $103.6M actually repurchased in FY2025. (c) Director Mark J. Hall's resignation effective 2026-08-01, reducing the Board from ten to nine. All three were found by reading the 8-Ks; none is reflected anywhere in the payload. This is the corporate-actions defect class, and Monster carries three instances.

4. est.ebitdaAvg and est.ebitAvg carry the fixed-ratio fabrication signature — REJECTED. ebitdaAvg is exactly 29.73% of revenueAvg and ebitAvg exactly 28.66% in every forward year FY2026-FY2030. Tested against the actual: FY2025 EBITDA of $2,604M on $8,294M is a 31.40% margin, so the fabricated ratio understates the real one by 5.4%. All forward valuation uses epsAvg.

5. profile.lastDividend reports 0.005208 and Monster has never paid a cash dividend — REJECTED as spurious. dividendYieldTTM is 0, dividendPerShareTTM is 0 and dividendPayoutRatioTTM is 0, all correct. The stray 0.005208 sits suspiciously close to the $0.005 par value disclosed on the 10-Q balance sheet ("Common stock - $0.005 par value; 5,000,000 shares authorized" — note that the authorised figure is in thousands). It could alternatively be an artefact of the 100% stock dividend mechanism used to effect the split. We do not assert which; we record that the field is wrong, that Monster pays no cash dividend, and that no yield is used anywhere in this dive.

6. enterpriseValueTTM omits short-term investments — the documented omission, quantified. The vendor reports $90.069B. Rebuild: market cap $92.109B − cash $2.088B − zero debt = $90.021B, a 0.05% match, which confirms the vendor deducted cash only. Deducting the $677.1M of short-term investments as well gives a corrected EV of $89.344B, 0.8% lower; adding the $487.3M of long-term investments gives $88.857B. The effect on EV/EBITDA is 32.45x → 32.18x and on EV/sales 10.24x → 10.16x — immaterial, and recorded for completeness rather than because it changes anything. Note the FY2024 bal_a row reports longTermInvestments of $6,000 (six thousand dollars) against $487.3M in FY2025 and $76.4M in FY2023, which is almost certainly a units error in a field this dive does not use.

7. returnOnEquityTTM is present in km_ttm (0.2546) and ABSENT from ratios_ttm — the recurring block asymmetry, fourteenth name running. The km_ttm figure of 25.46% is used. Unlike UPS, where a high ROE was a leverage artefact, Monster's is earned on an unlevered balance sheet — financial leverage of 1.243x — so returnOnInvestedCapitalTTM of 21.87% is close behind it and both are informative.

Share count — CHECKED AND EXACT. The 10-Q reports 977,916 thousand shares outstanding at 2026-03-31 (and 978,113 thousand at 2025-12-31) against 978,009 thousand implied by market capitalisation ÷ price. A 0.01% match.

Quote and technical blocks — minor 52-week disagreement. quote.yearHigh/yearLow report $100.34 / $58.54; tech.hi52/lo52 report $99.94 / $59.04. Differences of 0.4% and 0.8%. tech is used throughout for consistency with the moving averages. Note also that tech.max_dd_from_peak (−5.763%) is identical to tech.pct_from_hi to three decimal places, which means the stock's deepest drawdown in the measured window is its current one — i.e. Monster has not had a setback worse than 5.8% in the period. That is a plausible reading for a stock up 59.6% in twelve months, but it is also the signature of a drawdown field that simply reports the current distance from the high, and it is used descriptively rather than as a risk measure.

Non-equity tripwire — checked and passed. Common stock, $0.005 par value, NASDAQ-listed, per the 10-Q balance sheet. Price $94.18 is not par-like; beta 0.527; no dividend; volume 6.06M shares (~$571M of turnover); 52-week band $59.04-$99.94, a 69% range. This is common equity.

8. Technicals

Price $94.18, +0.4% above the 50-day moving average of $93.77 and +16.5% above the 200-day average of $80.85. The 50-day sits well above the 200-day: a clean uptrend configuration.
−5.8% from the 52-week high of $99.94; +59.5% above the low of $59.04. Position in the annual range: 86th percentile.
RSI 41.99 — the anomaly in the block. A stock 5.8% off its high, above both averages, with a 14-day RSI below 42 has been chopping sideways rather than advancing, which is consistent with a market that has already discounted the growth and is waiting for the print. MACD +0.35 — barely positive.
Maximum drawdown from peak in the measured window: −5.8% — identical to the current distance from the high (see Section 7).
Relative performance: 3-month +25.2% vs SPY +7.6% and QQQ +7.7%; 6-month +16.1% vs SPY +11.1%; 12-month +59.6% vs SPY +24.3% and QQQ +30.8%. Monster has outperformed the index at every horizon measured, by 5, 5 and 35 points. The twelve-month figure is the second-strongest in this batch.
Sentiment: 1 strong buy, 22 buy, 18 hold, 3 sell across 44 analysts; vendor consensus label Buy. Consensus target $96.27 (+2.2%), median $95 (+0.9%), high $105 (+11.5%), low $86 (−8.7%). The 23-buy rating distribution against a 2.2% consensus target is internally inconsistent and is a caution rather than a support: it means the ratings have not been updated for the price.

Today's move and what it does to the entry

Monster closed 2026-08-04 at $94.18, up 0.67% or $0.63 from $93.55, opening at $93.52 and trading $92.43 to $94.39 on 6.06M shares. No company-specific filing is dated 2026-08-04; the last was the 2026-07-08 split announcement.

The honest read: there is no entry here, in either direction, because the next two events are a print and a split. The stock is 0.4% above its 50-day average with RSI at 42 — mechanically neutral. Fair value is 0.9% above spot. Earnings are in two days. A position taken today is a bet on a print, not on a valuation, and this programme does not take those.

9. Insiders — two very large non-market transfers by the founders

Date	Person	Role	Type	Shares	Price	Held after
2026-05-22	Hilton H. Schlosberg	Director; Vice Chairman and CEO	J-Other	1,151,867	$0	1,359,681
2026-05-22	Hilton H. Schlosberg	Director; Vice Chairman and CEO	G-Gift	5,908	$0	1,353,773
2026-05-22	Rodney C. Sacks	Director (co-founder)	J-Other	697,495	$0	217,307
2026-05-22	Rodney C. Sacks	Director	G-Gift	11,585	$0	205,722
2026-06-10	Guy Carling	Officer: CEO, EMEA and OSP	S-Sale	19,000	$90.90	21,863
2026-07-08	Ana Demel	Director	A-Award	243	$0	20,107
2026-07-08	Tiffany M. Hall	Director	A-Award	122	$0	16,737
2026-07-08	Jeanne P. Jackson	Director	A-Award	302	$0	38,274

The reading, stated carefully because the transaction codes matter.

The two large items are J-Other transfers at $0, not open-market sales, and they must not be read as sales. Code J is "other acquisition or disposition" and at a zero price it is characteristically a transfer to a family partnership, trust or charitable vehicle rather than a disposal for cash. We report the magnitude and decline to characterise the intent, because the Form 4s themselves are not in this archive — only the vendor's summary fields.

The magnitudes are nonetheless the largest in this batch. Schlosberg transferred 1,151,867 shares — approximately $108 million at the prevailing price — and retained 1,353,773 after the subsequent gift. Sacks transferred 697,495 shares, approximately $65 million, and was left with 205,722 from a pre-transaction position above 900,000 — a reduction of roughly 77% in his directly held position. Both were executed on the same day, 2026-05-22, eight days after the Board approved the new $500 million repurchase authorisation and six weeks before the split was declared.

Two founders executing simultaneous nine-figure transfers of directly held stock is an estate- and control-planning event, and on a company these two men have run for three decades it is the succession question in transactional form. It is not a bearish signal about the business. It is a fact about the ownership structure that the filings in this archive do not explain, and it is reported as unexplained.

The only open-market transaction in the file is a sale: Guy Carling, CEO of EMEA and Other Strategic Products, sold 19,000 shares at $90.90 on 2026-06-10, retaining 21,863 — a 46% reduction, and the largest proportional reduction in the table. EMEA is the fastest-growing region in the company at +54.6% over three years, which makes the seller's identity mildly notable and the amount ($1.7 million) too small to be evidence.

Three director deferred-stock-unit awards on 2026-07-08 are mechanical. There is not one open-market purchase in the file.

10. Verdict, kill-criteria and flip conditions

Hold.

Struck two days before an earnings report and six days before a stock split, with both facts as inputs.

The arithmetic. At $94.18 Monster trades at 45.3x trailing, 40.9x the FY2026 consensus of $2.302 and 36.2x FY2027's $2.604, for consensus earnings growth of 13.1% — a vendor-computed forward PEG of 3.46. Our base fair value of $95 is 0.9% above spot, with asymmetry of 0.98:1 ($70 bear, $118 bull). The street's consensus target of $96.27 is 2.2% above spot despite 23 of 44 analysts carrying a Buy rating, which is a distribution that has not been reconciled to its own price targets. There is no dividend, and the buyback capacity of roughly $900 million is 1.0% of the market capitalisation against $103.6 million actually spent in FY2025.

What is genuinely excellent, and it is a lot. Five consecutive quarters of accelerating year-on-year revenue growth — −2.4%, +11.1%, +16.8%, +17.6%, +26.9% — with the most recent quarter at +22.1% currency-adjusted and operating margin at a nine-quarter high of 31.0%. Gross margin up 180 basis points to 55.8% on pricing and supply-chain work. Zero debt, approximately $3.25 billion of cash and investments, 25.5% return on equity, 21.9% on invested capital, 1.24x financial leverage, 806x interest coverage. Capital intensity of 1.6% of revenue, guided below $250 million through March 2027. Free cash flow of $1,966M on near-perfect conversion. And the data is clean: the segment blocks tie, the share count matches to 0.01%, and the capex and free-cash-flow fields — corrupt on nine names in this programme — are correct.

What holds it at Hold.

First, the price already contains all of it. 36.2x forward for 13% consensus growth. Our base and the street's target and the current price agree to within 2.2% of one another, which is the clearest possible statement that nobody in this file has an edge, including us.

Second, the acceleration is measured against a weak base and we will not extrapolate it. Q1 2025 was down 2.4% year on year. The two-year stack to Q1 2026 is +23.9%, or 11.3% annualised — the company's five-year rate. The +26.9% headline is real and the +22.1% currency-adjusted figure is the honest one; neither is a run rate until it survives a normal comparison, which is precisely what the August 6 print provides.

Third, the timing is wrong in two separate ways. Earnings in two days against a consensus that embeds deceleration to +15.0%; and a 2-for-1 split in six days that will make every number in this file superficially unrecognisable. Neither changes value. Both argue for waiting.

Fourth, the knowledge base is empty, and the reason is a data defect. One name-level claim, about Coca-Cola. The competitor set is unreachable because "Celsius" in this store means the failed crypto lender.

Pre-registered KILL criteria — what would take this to Avoid:

Currency-adjusted net sales growth below 12% in any quarter — a return to the five-year trend, which at 36x forward is worth roughly a fifth of the price.
Gross margin below 54%, giving back the entire FY2025 pricing gain.
Any material change to the Coca-Cola distribution arrangement, which the company itself names as a substantial dependency.
A US regulatory action on energy drinks — SNAP ineligibility, a GRAS reversal, a food-dye restriction or an age-of-sale rule — all six of which the company enumerates in its own risk language.
An Alcohol Brands impairment, after revenue fell from $184.9M (2023) to $172.3M (2024) to $134.7M (2025).
Operating margin below 28% on a non-seasonal quarter.

Pre-registered UPGRADE conditions — what would take this to Buy — Tactical:

A price below roughly $78 (pre-split; ~$39 post-split) on non-fundamental weakness, which is 30x FY2027E and restores asymmetry to better than 2:1.
Two consecutive quarters of currency-adjusted growth above 18%, which would establish that the FY2027 consensus of $2.604 is too low rather than the extrapolation risk it currently represents.
The full ~$900 million of repurchase authorisation deployed, after a year in which only $103.6M was spent — the clearest signal management could send about its own view of the price.
International mix above 45% of revenue with EMEA growth sustained above 15%.
An Alcohol Brands resolution — sale, closure or return to growth — which would remove a shrinking, unprofitable segment from the story.

Where MNST fits in the Synthos Framework Portfolio. No position today, and it is on the watch list at a price rather than at a date. This is a business we would want to own — debt-free, 25% on equity, reaccelerating, negligible capital intensity — at a multiple we are not being offered. The disciplined action is a limit at roughly $78 pre-split, or $39 post-split from 2026-08-11, and patience in the meantime. Logged as a tracked Synthos call (Hold) as of 2026-08-04 at $94.18, with the fair-value anchors, kill criteria and upgrade conditions all gradeable — and with the explicit note that all per-share anchors halve on 2026-08-11.

Single biggest risk: the multiple, not the business. At 36.2x the FY2027 consensus of $2.604 for 13.1% growth, Monster is priced for the current acceleration to persist well beyond what consensus itself models. The five-year compound revenue rate is 12.5%; the current currency-adjusted rate is 22.1%; the two-year stack implies 11.3%. If the true underlying rate is nearer the trend than the recent print, FY2027 EPS lands nearer $2.45 than $2.60, and a business growing 11% does not hold 36x. That is a 25-30% downside on no operational failure whatsoever — just a return to the company's own long-run rate. The balance sheet means Monster survives anything; the shareholder at 45x trailing earnings does not survive a normalisation without a large drawdown.

Provenance & disclosures

Traceability: 1 knowledge-base claim names Monster out of 54 raw hits (case-sensitive entity re-run: 1; used 1; discarded 53; breadth 1 channel, net conviction NONE). The claim — business_breakdowns, 2024-02-18, bullish 55, entities Coca-Cola/KO/Monster — is "Coke's ~20% Monster stake plus distribution access shows the network's pull; missing full ownership was a valuation call, not a strategic failure", i.e. a claim about Coca-Cola in which Monster is evidence. THE SWEEP IS DISCARDED IN ITS ENTIRETY and the lane is reported as empty rather than padded. Two discard modes: (a) a homograph collapse — every "Celsius" hit in this store is Celsius Network, the crypto lender that failed in 2022, not Celsius Holdings the energy-drink competitor, settled by forward_guidance 2025-06-25 (conviction 90) naming it with BlockFi, Genesis, Voyager, 3AC and Alameda; Monster's largest listed competitor is therefore unreachable through the obvious search term, and admitting those hits would have imported crypto-credit claims at conviction 90 into a beverage dive. (b) free-text noise — "monster" as an adjective (invest_like_the_best 2025-08-19: "a structural healthcare-cost inflationary monster") and seventeen caffeine-physiology hits from rhonda_patrick (12), huberman_lab (4) and peter_attia (1) that name no company. All hits carry speaker: null and are channel-attributed. No claim carries a management speaker_role. Conviction contributes zero to this verdict in either direction.
Data as-of: fundamentals — annual statements and segment/geographic detail through 2025-12-31 from the 10-K filed 2026-02-27; quarterly results, share count, liquidity and capex guidance through 2026-03-31 from the 10-Q filed 2026-05-08; corporate actions through 2026-07-08 from the 8-K record · estimates 2026-08-04 · prices 2026-08-04, quote timestamp 1785873601 = 2026-08-04T20:00:01Z ($94.18, +0.67%; 50-DMA $93.77; 200-DMA $80.85; RSI 41.99; MACD +0.35) · knowledge-base claims 2026-08-04. Monster's fiscal year is the calendar year. All figures come from the Synthos vendor data file for MNST or from the SEC filings in the MNST archive; no figure comes from memory, recall or external retrieval.
PRE-SPLIT WARNING. Every price, per-share, estimate, moving-average, 52-week and fair-value figure in this document is stated on a PRE-SPLIT basis. The 2-for-1 split declared 2026-07-08 is distributed after the close on 2026-08-10 and split-adjusted trading begins 2026-08-11. From that date, halve every per-share figure here and double the share count; no multiple, market capitalisation or fair value changes. The vendor payload contains no trace of the split and will require a forced re-pull after 2026-08-11.
Filing archive contents: 10-K filed 2026-02-27 (fiscal 2025 — the source of the gross-margin, net-sales and Alcohol Brands series); 10-Q filed 2025-11-07 (September 2025 quarter); 10-Q filed 2026-05-08 (March 2026 quarter — the source of the +26.9%/+22.1% net-sales disclosure, the share count, the repurchase-plan status and the capex guidance); 8-K filed 2026-05-15 (Item 5.07 annual-meeting voting results and Item 8.01, the new $500.0M repurchase authorisation of 2026-05-14); 8-K filed 2026-06-04 (Item 5.02, Mark J. Hall's Board resignation effective 2026-08-01, reducing the Board from ten to nine); 8-K filed 2026-07-08 (Exhibit 99.1, the 2-for-1 stock-split declaration). All six documents carry preserved [TABLE] statement data ("tables": true in the filings manifest).
Where the filings CONFIRMED the vendor: capital expenditure and free cash flow (FY2025 $132.3M capex, $1,966M free cash flow computed by subtraction; corroborated by "less than $250.0 million through March 31, 2027"); the share count (10-Q 977,916 thousand at 2026-03-31 against 978,009 thousand implied by market cap ÷ price, a 0.01% match); the FY2025 revenue of $8,294M and the Alcohol Brands decline to $134.7M (−21.8%); and the Q1 2026 revenue of $2,353.3M and operating income of $730.0M, both matching inc_q to the reported precision.
Where the vendor was REJECTED or incomplete: three corporate actions absent from every field — the 2-for-1 split, the $500.0M repurchase authorisation of 2026-05-14, and the Board reduction; est.ebitdaAvg/ebitAvg, exactly 29.73% and 28.66% of revenueAvg in all five forward years and 5.4% below the actual FY2025 EBITDA margin of 31.40% — all forward valuation uses epsAvg only; profile.lastDividend of 0.005208 on a company that has never paid a cash dividend (dividendYieldTTM and dividendPerShareTTM are correctly zero), a value suspiciously close to the $0.005 par value and possibly an artefact of the 100%-stock-dividend split mechanism — we record the field as wrong without asserting the cause; enterpriseValueTTM, which deducts cash but not the $677.1M of short-term investments, a 0.8% understatement of net cash whose effect on EV/EBITDA is 32.45x → 32.18x; bal_a FY2024 longTermInvestments of $6,000, three orders of magnitude out of line with the adjacent years and almost certainly a units error in an unused field; and returnOnEquityTTM present in km_ttm (0.2546) and absent from ratios_ttm — the km_ttm figure is used. quote.yearHigh/yearLow ($100.34/$58.54) differ from tech.hi52/lo52 ($99.94/$59.04) by 0.4% and 0.8%; tech is used throughout.
Where the vendor was CLEAN and it is recorded as a finding: seg_prod ties to 99.7% and seg_geo ties EXACTLY ($8,294.3M against $8,294M), with four correctly labelled geographies and no aggregate/component double-counting — a clean result on a defect class that failed on MDT, NEM, JCI, CDNS, CSX and UPS.
Estimate coverage: 18 analysts on FY2026 and FY2027 REVENUE but only 10 on EPS in each — the anchor for all three fair values, with an FY2027 EPS range of $2.464 to $2.833 (15.0%); 8 on FY2028 EPS; 6 on FY2029 and FY2030, used only as directional cross-checks.
Peer note: the vendor peer set — ABEV, CCEP, CL, COKE, DEO, KDP, KOF, KR, MDLZ, TGT — is a consumer-staples market-capitalisation cohort containing two retailers, an oral-care company and a spirits company. Monster's actual competitor set is absent. No peer-multiple comparison is drawn.
Fair-value caveat: the $70 / $95 / $118 anchors are multiples of the FY2027 consensus EPS distribution — 28.4x the low of $2.464, 36.5x the mean of $2.604, and 41.6x the high of $2.833 — cross-checked against FY2026 and FY2028 estimates and against the 52-week range. Stated arithmetic, not a discounted cash flow. The base assumes the multiple holds; it assumes neither re-rating nor de-rating, and holding a 36x multiple is a contestable choice that is stated as one. All three anchors are PRE-SPLIT and halve from 2026-08-11.
Basis note: earn_cal epsActual is on an adjusted basis and exceeds inc_q GAAP diluted EPS by 2 to 5 cents in four of the last five quarters, matching exactly in the most recent. The beat percentages quoted in Section 2 are therefore beats on adjusted EPS. The adjustment burden is small by this programme's standards (4-11%) and ran to zero in Q1 2026. Forward multiples use consensus EPS on the same adjusted basis; the 45.3x trailing multiple uses the vendor's trailing GAAP per-share figure.
Timing: second-quarter 2026 results are due 2026-08-06, TWO DAYS after this dive, against consensus of $0.581 EPS and $2,428.9M of revenue. The 2-for-1 split distributes after the close on 2026-08-10 with split-adjusted trading from 2026-08-11, six days after this dive. The most recent insider filings are dated 2026-07-10 (three director awards). 2026-08-04 carried no company-specific filing.
Accessibility note: no information in this dive is conveyed by colour. All emphasis is carried by bold text, table structure and explicit labelling.
Not investment advice. Independent research, educational and informational only, never personalised. No recommendation to buy, sell or hold any security is made to any person.
Version: 2026-08-04-full.